Singapore markets open in 4 hours 42 minutes

United Therapeutics Corporation (UTHR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
264.34+0.07 (+0.03%)
At close: 04:00PM EDT
264.34 0.00 (0.00%)
After hours: 04:10PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 11.72B
Enterprise value 9.62B
Trailing P/E 12.51
Forward P/E 11.26
PEG ratio (5-yr expected) 0.81
Price/sales (ttm)5.26
Price/book (mrq)2.20
Enterprise value/revenue 4.27
Enterprise value/EBITDA 8.00

Trading information

Stock price history

Beta (5Y monthly) 0.54
52-week change 323.26%
S&P500 52-week change 326.27%
52-week high 3269.81
52-week low 3204.44
50-day moving average 3240.56
200-day moving average 3230.54

Share statistics

Avg vol (3-month) 3533.09k
Avg vol (10-day) 3674.44k
Shares outstanding 544.37M
Implied shares outstanding 644.64M
Float 840.64M
% held by insiders 11.85%
% held by institutions 1105.76%
Shares short (30 Apr 2024) 43.85M
Short ratio (30 Apr 2024) 47.74
Short % of float (30 Apr 2024) 411.46%
Short % of shares outstanding (30 Apr 2024) 48.68%
Shares short (prior month 28 Mar 2024) 44.89M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 323 Sept 2009

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 42.05%
Operating margin (ttm)52.57%

Management effectiveness

Return on assets (ttm)12.25%
Return on equity (ttm)20.08%

Income statement

Revenue (ttm)2.5B
Revenue per share (ttm)53.18
Quarterly revenue growth (yoy)33.70%
Gross profit (ttm)N/A
EBITDA 1.31B
Net income avi to common (ttm)1.05B
Diluted EPS (ttm)21.12
Quarterly earnings growth (yoy)27.30%

Balance sheet

Total cash (mrq)2.71B
Total cash per share (mrq)61.05
Total debt (mrq)600M
Total debt/equity (mrq)11.24%
Current ratio (mrq)3.78
Book value per share (mrq)120.76

Cash flow statement

Operating cash flow (ttm)979.7M
Levered free cash flow (ttm)578.84M